IONIS-AGT-LRx

Angiotensinogen antisense oligonucleotide · Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for IONIS-AGT-LRx, covering 2023-01-06 to 2025-02-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure [Phase 2]

See pricing